Literature DB >> 2490426

Early indicators of prognosis in fulminant hepatic failure.

J G O'Grady1, G J Alexander, K M Hayllar, R Williams.   

Abstract

The successful use of orthotopic liver transplantation in fulminant hepatic failure has created a need for early prognostic indicators to select the patients most likely to benefit at a time when liver transplantation is still feasible. Univariate and multivariate analysis was performed on 588 patients with acute liver failure managed medically during 1973-1985, to identify the factors most likely to indicate a poor prognosis. In acetaminophen-induced fulminant hepatic failure, survival correlated with arterial blood pH, peak prothrombin time, and serum creatinine--a pH less than 7.30, prothrombin time greater than 100 s, and creatinine greater than 300 mumol/L indicating a poor prognosis. In patients with viral hepatitis and drug reactions three static variables [etiology (non A, non B hepatitis or drug reactions), age less than 11 and greater than 40 yr, duration of jaundice before the onset of encephalopathy greater than 7 days] and two dynamic variables (serum bilirubin greater than 300 mumol/L and prothrombin time greater than 50 s) indicated a poor prognosis. The value of these indicators in determining outcome was tested retrospectively in a further 175 patients admitted during 1986-1987, leading to the construction of models for the selection of patients for liver transplantation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2490426     DOI: 10.1016/0016-5085(89)90081-4

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  313 in total

1.  Indications for referral and assessment in adult liver transplantation: a clinical guideline. British Society of Gastroenterology.

Authors:  J Devlin; J O'Grady
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

Review 2.  Who needs a liver transplant? (new disease specific indications).

Authors:  A Baker; A Dhawan; N Heaton
Journal:  Arch Dis Child       Date:  1998-11       Impact factor: 3.791

3.  Orthotopic liver transplantation for fulminant hepatitis B.

Authors:  Xiao-Shun He; Jie-Fu Huang; Gui-Hua Chen; Qian Fu; Xiao-Feng Zhu; Min-Qiang Lu; Guo-Dong Wang; Xiang-Dong Guan
Journal:  World J Gastroenterol       Date:  2000-06       Impact factor: 5.742

4.  Portal hemodynamics in fulminant hepatic failure as assessed by duplex Doppler ultrasonography.

Authors:  Y Chawla; A Sreedharan; R K Dhiman; S Jain; S Suri
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

5.  Unrecognized acetaminophen toxicity as a cause of indeterminate acute liver failure.

Authors:  Niraj Khandelwal; Laura P James; Corron Sanders; Anne M Larson; William M Lee
Journal:  Hepatology       Date:  2011-01-10       Impact factor: 17.425

6.  Paracetamol overdose: the liver unit perspective.

Authors:  M Iqbal; W J Cash; S Sarwar; P A McCormick
Journal:  Ir J Med Sci       Date:  2011-11-10       Impact factor: 1.568

7.  Prevalence, Severity, and Impact of Renal Dysfunction in Acute Liver Failure on the US Liver Transplant Waiting List.

Authors:  Nathalie H Urrunaga; Laurence S Magder; Matthew R Weir; Don C Rockey; Ayse L Mindikoglu
Journal:  Dig Dis Sci       Date:  2015-09-19       Impact factor: 3.199

Review 8.  Acute liver failure.

Authors:  J G O'Grady
Journal:  Postgrad Med J       Date:  2005-03       Impact factor: 2.401

Review 9.  [Extracorporeal therapy of patients with liver disease in the intensive care unit].

Authors:  V Fuhrmann; T Horvatits; A Drolz; K Rutter
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-04-27       Impact factor: 0.840

10.  A Learning Collaborative Approach Increases Specificity of Diagnosis of Acute Liver Failure in Pediatric Patients.

Authors:  Michael R Narkewicz; Simon Horslen; Regina M Hardison; Benjamin L Shneider; Norberto Rodriguez-Baez; Estella M Alonso; Vicky L Ng; Mike A Leonis; Kathleen M Loomes; David A Rudnick; Philip Rosenthal; Rene Romero; Girish C Subbarao; Ruosha Li; Steven H Belle; Robert H Squires
Journal:  Clin Gastroenterol Hepatol       Date:  2018-04-30       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.